Taking a cue from the emerging data on tissue-specific effects on T cell phenotypes, Adu-Berchie and Liu et al. found that viscoelasticity (time-dependent response to stress), but not stiffness, impacted T cell RNA signatures (comparing tumor, adjacent normal tissue, or blood), and this could be recapitulated in vitro with specially cross-linked collagen matrices. Short-term activation of T cells, including CAR T cells, exposed to “slow-relaxing” matrices durably imprinted a transcriptome enriched in transcription factors in the AP-1 family, and a phenotype with enhanced in vitro and in vivo killing capability and effector molecule expression. Long-term “chronic” activation abrogated these effects.
Contributed by Ed Fritsch
ABSTRACT: The efficacy of adoptive T-cell therapies largely depends on the generation of T-cell populations that provide rapid effector function and long-term protective immunity. Yet it is becoming clearer that the phenotypes and functions of T cells are inherently linked to their localization in tissues. Here we show that functionally distinct T-cell populations can be generated from T cells that received the same stimulation by altering the viscoelasticity of their surrounding extracellular matrix (ECM). By using a model ECM based on a norbornene-modified collagen type I whose viscoelasticity can be adjusted independently from its bulk stiffness by varying the degree of covalent crosslinking via a bioorthogonal click reaction with tetrazine moieties, we show that ECM viscoelasticity regulates T-cell phenotype and function via the activator-protein-1 signalling pathway, a critical regulator of T-cell activation and fate. Our observations are consistent with the tissue-dependent gene-expression profiles of T cells isolated from mechanically distinct tissues from patients with cancer or fibrosis, and suggest that matrix viscoelasticity could be leveraged when generating T-cell products for therapeutic applications.